Table 1.
A summary of the datasets.
| GSE157103 (12) | ||
|---|---|---|
| Tissue resource | Leukocyte from COVID-19 patients | |
| Sample size | n = 100 | |
| Demographic characteristics | ||
| Female sex – No. (%) | 38 (38) | |
| Age Range – No. (%) | ||
| Younger than 49 | 22 (22) | |
| 50–59 | 21 (21) | |
| 60–69 | 21 (21) | |
| 70–79 | 19 (19) | |
| 80 and older | 16 (16) | |
| Missing data | 1 (1) | |
| Clinical characteristics | ||
| ICU admission – No. (%) | 50 (50) | |
| Hospital free days at 45 days | 26 (median) | |
| Mechanical ventilation – No. (%) | 42 (42) | |
| Ventilator-free days | 28 (median) | |
| APACHE II score | 21 (median) | |
| SOFA score | 7 (median) | |
| Laboratory findings | ||
| C-reactive protein (mg/L) | 128.2 (median) | |
| Ferritin (μg/L) | 652 (median) | |
| Procalcitonin (μg/L) | 0.57 (median) | |
| D-dimer (mg/L) | 1.79 (median) | |
| Lactate (mmol/l) | 1.17 (median) | |
| GSE152075 (14) | ||
| Tissue resource | Nasopharyngeal swabs from COVID-19 patients | |
| Sample size | n = 430 | |
| Demographic characteristics | ||
| Female sex – No. (%) | 201 (46.7) | |
| Male sex – No. (%) | 176 (40.9) | |
| Missing data | 53 (12.3) | |
| Age Range – No. (%) | ||
| Younger than 49 | 157 (36.5) | |
| 50–59 | 84 (19.5) | |
| 60–69 | 53 (12.3) | |
| 70–79 | 63 (14.7) | |
| 80 and older | 56 (13.0) | |
| Missing data | 17 (4.0) | |
| GSE156063 (13) | ||
| Tissue resource | Nasopharyngeal swabs from COVID-19 patients | Nasopharyngeal swabs from patients infected with other viruses |
| Sample size | n = 93 | n = 41 |
| Demographic characteristics | ||
| Female sex – No. (%) | 50 (53.8) | 19 (46.3) |
| Age Range – No. (%) | ||
| Younger than 49 | 59 (63.4) | 23 (56.1) |
| 50–59 | 10 (10.8) | 3 (7.3) |
| 60–69 | 16 (17.2) | 6 (14.6) |
| 70–79 | 7 (7.5) | 5 (12.2) |
| 80 and older | 1 (1.1) | 4 (9.8) |